Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 9Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Mouth Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Uterine Cervical Neoplasms 1Sentinel Lymph Node Biopsy (SLNB) 1Sarcoidosis, Pulmonary 1Sarcoidosis 1Rhabdomyosarcoma 1Recurrence 1Recurent Vulvar Carcinoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Melanoma 1Lymphoma 1Lymphatic Metastasis 1Lung Neoplasms 1HIV Infections 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Eyelid Sebaceous Gland Carcinoma 1Cervical Adenocarcinoma 1Carcinoma, Squamous Cell 1Carcinoma, Ductal 1Anus Neoplasms 1

Interventions

pembrolizumab 1Yoga 1Taxes 1Specimen Handling 1Sentinel Lymph Node Biopsy 1Salpingo-oophorectomy 1Radiation 1Platinum 1Paclitaxel 1Immunoglobulin G 1Disulfides 1Congresses as Topic 1Cisplatin 1Brachytherapy 1Bevacizumab 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cervical Adenocarcinoma × Sentinel Lymph Node Biopsy × 1 year × Clear all
NCT01048853 2026-01-07

Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer

M.D. Anderson Cancer Center

Phase NA Terminated
137 enrolled 15 charts
Gynecologic

Cervical Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡